Physician profile
Stephen P Murphy
NPI 1003845611
$2,187.04
in general payments reported to CMS, 2019-2025
14 companies · $221 in 2025
The $221 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,088 · 2020: $168 · 2021: $193 · 2022: $123 · 2023: $164 · 2024: $231 · 2025: $221.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $616.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $615.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $1,096.13 | 2019-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $434.19 | 2019-2025 | Jardiance |
| Novartis Pharmaceuticals Corporation | $260.37 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $59.79 | 2019 | |
| Astrazeneca Pharmaceuticals Lp | $57.69 | 2019-2025 | Breztri |
| Glaxosmithkline, LLC. | $52.06 | 2019-2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $50.82 | 2019 | |
| Amgen INC. | $39.71 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $37.81 | 2019 | |
| Biohaven Pharmaceuticals, INC. | $27.98 | 2021 | |
| Kowa Pharmaceuticals America, INC. | $27.86 | 2019 | |
| Pacira Therapeutics, INC. | $18.73 | 2019 | |
| Novo Nordisk INC | $12.37 | 2021 | |
| Horizon Therapeutics Plc | $11.53 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephen Murphy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.